Skip to main content
. 2007 Oct;3(5):795–805.

Figure 4.

Figure 4

Change in myocardial T2* at 6 and 12 months in patients taking deferiprone or deferoxamine. Reproduced with permission from Pennell DJ, Berdoukas V, Karagiorga M, et al 2006. Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis.